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Resumo 
 
 
A histeroscopia é hoje uma técnica imprescindível em ginecologia 
quer no diagnóstico de alterações genitais superiores, quer no 
tratamento minimamente invasivo, sendo segura, fiável e com 
poucos efeitos secundários e complicações. A miniaturização dos 
aparelhos juntamente com aperfeiçoamento técnico 
(nomeadamente com a abordagem vaginoscópica, sem recurso a 
espéculo, nem a tração do colo) vieram permitir o seu uso em 
consultório. Usado sem anestesia reduz os riscos do internamento 
e tornam o exame acessível; tem contudo a limitação da dor 
provocada pela instrumentação. Apesar de muitas tentativas 
analgésicas e anestésicas, o controlo da dor não é satisfatória em 
algumas doentes nas quais a histeroscopia é difícil de suportar. 
Este trabalho pretende estabelecer se a dor é menor com os mini 
histeroscópios do que com os instrumentos convencionais, avaliar 
quão grave é o problema da dor (quantificando a proporção de 
mulheres que se queixam) mesmo com este aparelhos mais 
delgados e tentar saber se existem fatores de risco que favoreçam 
a dor, ou que pelo contrário protejam a doente. Também se 
pretende estabelecer se os inquéritos de satisfação às doentes se 
correlacionam com a pontuação de dor e se a ansiedade interfere 
com as queixas álgicas. Finalmente também tentámos investigar 
se uma técnica nova de anestesia local, administrada através do 
histeroscópio com recurso a uma agulha cistoscópica, reduz a dor 
e torna o exame mais tolerável. 
Os resultados mostraram haver redução estatisticamente 
significativa da perceção da dor com mini histeroscópios em 
relação a aparelhos convencionais. Mostraram ainda que mesmo 
com calibres finos há uma proporção de doentes entre 13 e 30% 
que ainda refere dor moderada a severa e que reduzir o calibre 
abaixo dos 3,5mm pode não resultar numa redução maior da dor. 
Quanto a fatores de risco para a dor os nossos resultados não 
encontraram relação, exceto uma proteção na dor para as doentes 
obesas, que relacionamos com uma maior impregnação hormonal 
(androgénica e por via da aromatase, estrogénica). A ansiedade 
não parece ser importante na dor sentida, ainda que exista uma 
pouco significativa relação entre traço ansioso e intensidade da 
dor relatada. No que se refere aos questionários de satisfação, 
correlacionam-se muito bem com a dor reportada, tendo uma boa 
sensibilidade e especificidade; sendo simples de administrar e 
fáceis de interpretar poderiam provavelmente substituir as escalas 
da dor e ser úteis para eventual seleção das doentes a quem 
administrar a anestesia local histeroscópica. Finamente a técnica 
histeroscópica de injeção local de anestésico reduz 
significativamente a dor e poderá ser uma solução para tornar a 
intervenção suportável em ambulatório. 
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Abstract 
 
Hysteroscopy today is an essential tool in gynaecology both for diagnosis 
of female upper genital tract abnormalities and for minimally invasive 
surgery procedures. It is safe, reliable and has few side effects and 
complications. Diminishment of instrument diameter together with 
technical improvements (such as the vaginal “no touch” approach without 
use of speculum or cervical traction) has allowed procedures in office 
environment. Used without analgesia or aneasthesia it has reduced 
hospitalization risks and made the examination affordable; it has a 
drawback which is the level of pain some women refer with 
instrumentation. Although many attempts with the use of analgesics and 
anaesthetics have been made, pain control is not satisfactory in some 
patients for whom hysteroscopy is hard to endure. 
In this work we aim to establish if pain reporting is lower with mini-
hysteroscopes compared to conventional scopes, how big is the problem 
“pain” (quantifying the proportion of women still complaining) even when 
using the slender mini-scopes and try to establish if there are risk factors 
which might influence pain reporting, or on the contrary protect, women 
from agony. We also explored if satisfaction questionnaires correlate well 
with pain scores and if patient anxiety interferes with pain. Finally we have 
investigated if a new local anaesthetic administration technique, with the 
use of a cystoscopic needle through the hysteroscope, can reduce pain and 
make the procedure more tolerable. 
Our results show there is a statistically significant reduction of pain scores 
when using mini-hysteroscope compared to conventional instruments. 
They also show that even using smaller caliber scopes there is a proportion 
of women varying from 13 to 30% who will still complain of moderate to 
severe pain and that reduction of scopes below 3.5mm diameter may not 
reduce pain scores any further. As to risk factors for pain, our results have 
not found relation to pain with risk factors except for some protection for 
pain in women with high body mass index, and we relate this finding with 
elevated circulating hormones (androgens which are peripherally converted 
to estrogens via aromatase in adipose tissue). Anxiety does not seem 
important in pain reporting, even if a slight statistical significance was 
found between anxiety trait and pain reporting. As to satisfaction 
questionnaires, they seem to correlate well with the pain experience and 
show and excellent sensitivity and specificity: simple to administer and 
easy to interpret, they could probably replace more complicated pain rating 
scales and be useful in selecting women who would benefit from local 
anaesthesia. Finally as to the new technique of applying local anaesthetics 
“hysteroscopic anaesthesia”, results show a statistical reduction of pain 
after injection and it could become a practical solution in making 
hysteroscopy bearable in an office setting. 
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PART 1- INTRODUCTION 
1 Hysteroscopy 
1.1 What is hysteroscopy?  
Hysteroscopy is a procedure used for diagnostic purposes or for minimally invasive surgery, 
and is performed with endoscopes [1]. They can be flexible or rigid rods with diameters ranging 
from 3.1mm to 5mm (for outpatient office diagnostic and minimally invasive surgery) to 10mm 
outer sheet diameter scopes (appropriate for ressectoscopic surgery under general anaesthesia 
for these larger hysteroscopes require mechanical cervical dilatation which is painful). 
The device, whichever it´s calibre, has a lens system, a working channel all along its length for 
use with hysteroscopic instruments (forceps, scissors and various electrodes and probes) as well 
as for distension media flow (which can be carbon dioxide or various liquid media). Recently 
normal saline has substituted most liquid media for its safety and because new bipolar electric 
probes work in this media.  
The hysteroscope (figures 1 and 2) is operated by inserting the rod through the vagina, tackling 
the cervical canal and entering into the endometrial cavity. The aim is to provide a panoramic 
view of the upper genital tract through an eyepiece, which in modern apparatus is attached to a 
camera, and images can be displayed on a screen. Photographs and videos can be taken and 
recorded, stored for future visualization and comparison or specialist training. Finally to be able 
to view images, a light source must be attached. 
 
 
 
Figure 1 – unattached hysteroscope 
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Figure 2 – fully attached hysteroscope ready for use 
 
1.2 Evolution of hysteroscopy: Development 
The first ever use of the concept of examining body cavities with the aid of a tube is attributed 
to Phillip Bozzini, a German physician, in 1806. The contraption was no more than a box with a 
candle light with two attachments: an eye piece on one side and a collection of interchangeable 
hollow pipes at the other end. Dr Bozzini placed a mirror inside the box to reflect the light into 
the pipes, allowing illumination from the flame of a candle stick to the interior of the bodily 
orifices [1, 2]. 
Almost fifty years later, in 1853, Désormeaux used a lamp burning turpentine and alcohol with 
a chimney attached to an optical-like tube, calling this apparatus “endoscope”. This strange 
looking instrument had reflecting mirrors and condenser lenses which increased lighting and 
was used for urological examinations and treatments, becoming not only a diagnostic 
instrument, but also a promising therapeutic tool [1, 3].  
Pantaleoni is credited as the first to use such an instrument in female care in 1869. He diagnosed 
an endometrial polyp as the source of abnormal uterine bleeding and treated it by cauterizing 
with silver nitrate. [4]. However, visualization of the uterine cavity through this hollow tube was 
hard as the uterus is not very distensible and uterine mucosa tends to bleed, compromising 
direct visualization.  
The German physician Nitze was responsible for modernizing the endoscope and creating the 
cystoscope in 1877. He sealed off the extremities with lenses and attached lighting to the far end 
of the rod using a platinum wire loop; this apparatus was subsequently introduced into the 
bladder distended by water. Later innovations in 1879 included filament lighting by 
miniaturizing Edison’s electric bulb invention [1].  
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1.3 Technical Improvements: Contact Hysteroscopy 
The first examinations of the utero were made without expanding the cavity — contact 
hysteroscopy —, the same technique used by Desormaux [3]. On the other hand, Pantaleoni was 
the first to perform the examination on a living person [4].  
Following initial generalized disappointment with “panoramic” examinations due to media 
distension issues, Marleschki in 1962 had suggested that returning to contact hysteroscopy 
could be of value [5]. He introduced an instrument with a 12.5 magnification power and 
inaugurated micro hysteroscopy, a device with which one is able to observe details at the scale 
of the cell; it is still of utility in gynaecological practice [6]. A few years later in 1972 Vulmiere 
patented a device for contact hysteroscopy [7].  
Constant modernization and the quest for better diagnostics, global visualization and operating 
conditions, brought about the issue of distension of the walls of the womb as a necessity for 
quality examinations.  
Nonetheless, in the 1980’s, Hamou presented yet still one more contact apparatus with 
magnification adequate for microcolpohysteroscopy — histology studied in the living person [5, 
8]. But the idea subsequently lost followers. Nowadays there are still authors who find 
usefulness in the device, particularly as a complementary study to panoramic hysteroscopy [5].  
1.4 Distension and panoramic Hysteroscopy 
The pursuit for global visualization of the cavity implied distension and various attempts were 
made. Distension devices were conceived and the new tools for panoramic hysteroscopy gained 
the preference of gynaecologists.  
 In 1925, Rubin initially used air and then carbon dioxide for this objective. Many physicians 
including German pioneers such as Mikulicz-Radecki preferred low viscosity fluids [9].  In 
1928, Gauss [10] was the first to use water, but reported bleeding and the mixing of blood, 
which hindered vision. A second problem referred by Gauss, Schroeder and Segond  was fluid 
passage to peritoneum and blood stream, which could cause vascular overload [9]. Schroeder 
established minimum intra-uterine pressure for visualization in panoramic hysteroscopy around 
25 to 30 millimetres of mercury (mmHg). Until the sixties and seventies, no great change 
occurred in hysteroscopy and various authors used instruments similar to Gauss, Schroeder and 
Segond with in and outflow of fluids [9]. Since 1970 Lindemann worked in perfecting carbon 
dioxide inflators for hysteroscopy [11]. Still popular in office settings, recent data seem to 
support this media use for diagnostic purpose [12]. Also in the 1960’s, pioneers experimented 
hysteroscopy with rubber balloons but this method didn’t allow biopsies and was soon 
abandoned [13]. 
Edstrom and Fernstrom, in 1970, experimented with pumps delivering high viscosity liquid 
media non-miscible with blood [14]. Although they provide good quality viewing even with 
haemorrhage, there are safety problems and technical difficulties associated with their use. As to 
low viscosity fluids, the electrolyte free fluids such as 1.5% glycine, 3% sorbitol and 0.5% 
mannitol all provide excellent visibility [15]. However, they also have complex safety 
restrictions and it would be wise to discontinue their use. Glycine, in particular, apart from 
cautions, is nonconductive and would seem adequate for mono-polar electro-surgery, so debate 
remains about its utility [15].  
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Finally, there are normal saline and other electrolytes containing media which are safe for 
patients, although inadequate for mono-polar surgery [15]. Fortunately, the development of bi-
polar electrodes that work in saline solutions, have been made available for use in 
gynaecological care.  The American Association of Gynecologic Laparoscopists - AAGL has 
issued guidelines in which it questions the usefulness of some of these media nowadays, mainly 
high viscosity media [15]. A summary of the existing distension media in use is given in Table 
I, along with the advantages and disadvantages of each choice. 
 
Table I 
Issues and cautions with distention media 
Distension Media Characteristics of media  
CO2 Only diagnostic; may increase patient 
discomfort  
High viscosity fluid (32% dextran 70) Allergic reaction, coagulopathy, vascular 
overload, caramelize on instruments rendering 
them useless 
Low viscosity fluid (3% sorbitol, 1,5% 
glycine, 5% mannitol) 
Good for monopolar, may cause severe fluid 
and electrolyte disturbance, with life 
threatening hyponatremia and hypo 
osmolality, especially dangerous in pre-
menopausal women 
Normal saline Safe media, does not cause electrolyte 
imbalance, adequate for bipolar electrodes 
 
1.5 Optics and Lighting 
The first great improvement in lighting conditions was brought by a miniaturized version of 
Edison’s light bulb, fitted at the tip or far end of the rod.  In 1952, Fourestier replaced the glass 
in the endoscope for a full size 1.5 mm diameter quartz rod encased by a steel sleeve and having 
a total of 2 mm diameter; this light guide was introduced into a rigid endoscope with a 15 V 
lamp and condenser lens at the proximal end. The instrument transmitted a clear filtered light 
into the body cavities. Although the optical quality was excellent, the apparatus was awkward to 
use [1].  
In 1955, Hopkins, a physician keen on physics, [16] replaced the classic thin glass lenses of the 
Nitze endoscope for a total length rod of coherent optic grade glass (optic fibres) instead of 
small lenses separated by air and revolutionized endoscopes bringing a clear amelioration in 
lighting [17]. A further added advantage was the reduction of endoscope diameters, leading to 
the invention of a paediatric cystoscope [1]. Around 1959 Karl Storz manufactured the first 
complete set, initiating the golden age for rigid instrument endoscopy [17]. Vulmiere, in 1972, 
patents a much elaborated endoscope using a continuous glass fibre rod, allowing both 
illumination and observation and with two options: direct vision and lateral vision [7]. His 
endoscope was soon coupled with glass fibre connections, allowing the use of powerful external 
“cold light” source, thus revolutionizing endoscopy. 
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1.6 Surgery and Hysteroscopy 
The first ever gynaecological treatment through an endoscope is attributed to Pantaleoni [4]. As 
technique evolved with better and slender endoscopes, so did surgical tools and options. 
Norment was quite an innovator and, in 1957, it seems to have been his idea, to fit a resecting 
loop, at the tip of his endoscope for polyp excision [18]. A decade later, Neuwirth reports a 
successful monopolar loop resection of sub mucous leiomyoma with a urologic resectoscope [9, 
19, 20]. So begins a new era in surgical endoscopic care in gynaecology. 
Goldrath used Yttrium Aluminium Garnet  (YAG) laser to successfully perform endometrial 
ablation in 1981 [21] and such works were rewarded by the FDA’s approval of YAG laser in 
1986. Valle published his results on endoscopy surgery in 1990, using various methods 
including electrocoagulation, rigid and semi-rigid scissors and forceps, transection of the 
pedicle and dissection plus enucleation of myomas primarily for treatment of infertility [22]. 
Electro surgery was developing quickly, using loop resection and rollerball coagulation which 
were cheaper and equally effective, so in 1989 the health care regulator also approved 
resectoscopy for the same indications, namely symptomatic endometrial polyps and leiomyomas 
[23, 24].  
At the turn of the XXI century in his editorial “Endometrial resection and ablation: past, present 
and future” published in Gynaecological Endoscopy, David Parkin from Aberdeen summarizes 
the State of the Art [25]. He elaborates on available techniques such as Endometrial Laser 
Ablation (ELA) and compares it to Trans Cervical Resectoscopic Ablation (TCRA). Results 
were expressed on patient satisfaction for heavy bleeding control and he finds that both methods 
lead to dramatic decrease in the need for hysterectomy. He is sceptical about alternative and 
emerging endometrial destruction methods, such as thermal balloon and microwave, but he 
recommends randomized controlled trials. Indications are systematized, prognostic factors are 
pointed out and the importance of using guidelines is stressed. Finally he expresses concerns 
about adequate training of endoscopic gynaecologists and establishes perspectives for the 
evolution of endoscopy. He also suggests that pharmacological preparation prior to surgery 
could enhance success [25]. 
Ten years later, in 2010, Umranikar reviews indications, equipment options and techniques and 
compares results between first generation (TCRA, rollerball and laser) and second generation 
(thermal laser, hydro ablator, cryoablation, microwave ablation, electrode ablation, and 
impedance controlled bipolar radiofrequency ablation) techniques [26]. He concludes that 
results, as well as patient satisfaction, were comparable and distinguishes two major treatment 
goals: bleeding control and infertility treatment. Pointing out the importance of classifying sub 
mucous fibroids according to The European Society of Hysteroscopy score, he argues that such 
classification has a prognostic value on treatment strategy. As to the novel treatment option, 
impedance controlled bipolar radiofrequency ablation proposed by Gallinat [27], he agrees that 
it is effective, safe and seems promising for less experienced hysteroscopic surgeons. 
In 2013, Emanuel published a paper similar to Umranikar’s in 2010, generally sanctioning the 
same points of view. He does, however introduce a new morcellation instrument tested by Van 
Dongen [28] and  described by Cohen [29], seemingly easier to use even by less experience 
surgeons. It is expected to  cut operating time so it should be an instrument with a bright future 
in hysteroscopy [30].  
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1.7 Hysteroscopy today 
Hysteroscopy allows direct visualization of the cervical canal and endometrial cavity. As a 
diagnostic device it is very useful in investigating uterine abnormal bleeding where it is 
considered the gold standard [31-36]. Its objective is the examination of the female upper 
genital  tract through direct visualization of the cervical canal and endometrial cavity frequently 
leading to the discovery of unsuspected pathologies, such as polyps and fibroids [37].  
 
Hysteroscopy allows diagnosis of endometrial hyperplasia and cancer [38, 39] and permitting 
histological sampling, it confirms the nature of lesions [40-42]. Endometrial biopsy may even 
be useful in cancer staging by ruling out cervical involvement [43-45]. Also, successful attempts 
have been made to use hysteroscopy for the sentinel node technique in endometrial malignancy 
[46, 47], to identify which nodes are involved and tailoring the surgery to patient’s needs. 
Concerns about spreading neoplastic cells into the peritoneum with hysteroscopy [48] may not 
be justified, as the procedure appears to be safe [47, 49, 50].Foreign bodies can be detected and 
retracted with adequate tools [51]. Or, on the other hand, inserted into the fallopian tubes, for 
instance, for sterilization purposes [52-54]. Some authors consider hysteroscopy essential in 
routine work up of infertile women [55-57], revealing unsuspected intra uterine mass, adhesions 
and mullerian malformations [58-60].  
Modern office hysteroscopes and mini-hysteroscopes, smaller in diameter (2.9mm to 5mm), 
avoid cervical dilation [61-63] and together with technical improvements, such as the 
vaginoscopic no-touch approach [64-66], have improved patient tolerance and allow the 
procedure to be performed without analgesia or anaesthesia [63], although pain is not 
completely managed [62, 67-73].  
Office hysteroscopy and surgery have become popular and cost effective, treating various 
conditions: placental remains [74], myoma and polyp ablation [75-78], uterine septum 
(conventional hysteroscopy) [79, 80] and vaginal septum resection [81], and trans cervical 
sterilization [82] safely and at a very low cost [83]. 
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1.8 Advantages of hysteroscopy  
 Safe [23, 30, 61, 84] 
 Reliable [23, 61] 
 Cost effective [36, 61, 76, 85, 86]  
 Very accurate in diagnosis [23, 61, 76, 86] 
 Easy to perform even for less skilled operator [68] 
 Allows sampling for histopathology [23, 61] 
 Minimally invasive diagnostic and surgical tool [61] 
 Very rapid recovery and low morbidity [61, 86] 
 Gold standard tool for investigating uterine abnormal bleeding [31-36, 61, 63, 
68]  
 “An operative gold standard technique and an important contribution to Patient 
Safety” [83] 
 
1.9 Disadvantages 
 Although it is a minimally invasive technique it still requires the introduction of 
an endoscope into the vagina, through the cervical canal all the way into the 
endometrial cavity [23, 61].  
 Operators need to acquire skills [61, 87, 88],  
 Some patients will not easily tolerate the operation [61, 68], 
 Possible complications may follow (immediate or late in onset) [23, 38, 89-91] 
 
1.10 Indications for Hysteroscopy 
Diagnosis: 
 Uterine abnormal bleeding (metrorrhagia, heavy bleeding, post-menopausal 
bleeding) [33-35, 40, 61, 88, 92, 93] 
 Infertility [37, 56-58, 61, 94-97] 
 Genital malformations (septate uterus, septate vagina, septate uterus) [61, 98, 
99] 
 Thicken endometrium on a previous transvaginal ultrasonography [40, 61] 
 Endometrial and endo-cervical cancer suspicion, staging and confirmation 
[46, 47, 61] 
Diagnosis and treatment: 
 Septate genital malformations (surgical removal) [80, 100] 
 Endometrial or endo-cervical ablation of polyps or myomas [23, 24, 78, 101] 
 Female sterilization (fallopian tube occlusion) [78, 102-105] 
 Ressectoscopic removal and follow up of myomas and endometrial 
hyperplasia [22, 106-111] 
 Retraction of foreign bodies in endometrial cavity (placental or embryonic 
remains, IUD lost in the cavity) [74, 112-117] 
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1.11 Complications of hysteroscopy 
Hysteroscopy is very safe and complications are infrequent. However they may arise and 
caution should be used to avoid and treat any unforeseen difficulty [102, 118-120]. 
Possible complications associated with hysteroscopy (Table II):  
 
 
Table II 
Possible perioperative complications in hysteroscopy 
Cause Consequence 
Patient positioning Neurologic and compartment syndrome 
Anaesthesia Allergy, systemic injection, overdose 
Access issues Cervical trauma and perforation 
Distending media Fluid overload, electrolyte imbalance 
Gas emboli CO2 or air in blood vessels 
Perforation Uterus, adjacent structures (bowel, bladder, vessels)  
Bleeding Endometrium, myometrium, periuterine vessels  
Electrosurgical Local (active electrode) or remote (currant diversion) burns 
Infection Endomyometritis, peritonitis 
Late complications Adhesions, pregnancy related (uterine rupture, placenta acreta) 
 
Cervical preparation with misoprostol before procedure facilitates operative management [121], 
in both menopausal [122] and premenopausal women [123]. Preparation alone will 
unfortunately not avert complications which may arise from various conditions and so extreme 
attention must be paid to technique and to possible accidents and incidents [118]. One can 
minimize accidents by following a strict surgical protocol, respecting indications and excluding 
patients who are thought high risk and ruled inadequate for the procedure [118]. Patient 
positioning and vital signs monitoring together with close checking of equipment are very 
important. It should be emphasised that the surgeon has to pay close attention to signs of 
incidents or accidents [118]. 
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2. Pain 
Pain can be defined as an “Unpleasant sensation associated with a specific part of the body” 
which makes it much more than just an automatic reaction to a nociceptive stimulus [124].  
2.1 Pathophysiology of Pain [124, 125] 
The Primary Afferent Nociceptor involves three different types of neurons, which are present in 
tissues and peripheral nerves: primary sensory afferents, motor neurons, and sympathetic 
postganglionic neurons. The cell bodies of primary sensory afferents are located in the dorsal 
aspect of the vertebral root ganglia adjacent to conjugated orifices. This cell’s primary afferent 
axon has one branch projecting centrally into the spinal cord and another branch reaching 
peripherally to innervate tissues.  These fibres differ in thickness, degree of myelination, and 
signal transmission speed.  
A-beta (Aβ) large-diameter afferent fibres are present in nerves which innervate mostly the skin 
and essentially respond to tactile perception (soft touch or moving stimuli). These fibres do not 
normally respond to pain. Two other classes of primary afferents have been described: the 
small-diameter myelinated A-delta (Aδ) and the unmyelinated (C-fibre) axons. Aδ and 
unmyelinated C-fibres innervate the skin and also deep somatic and visceral structures. They all 
respond to high intensity mechanical stimulation and are so called high-threshold mechano 
receptors but some Aδ are responsive to both mechanical and heat stimuli (high-threshold 
mechanothermal receptors). C-fibres are slow conducting nonmyelinated and transmit 
nociceptive information from a broad diversity of insults (mechanical, thermal and chemical). 
They are designated C-polymodal nociceptors. So Aδ and C afferent fibres are mainly 
responsible for most of the pain impression, reacting to intense stimuli as primary afferent 
nociceptor response and when, by any reason their transmission is blocked, conduction of pain 
is interrupted.  
The process by which free nerve endings translate a noxious insult into nociceptive impulse is 
called Transduction.  The Aδ and the unmyelinated fibres show their maximal nociceptive 
response (painful sensation) only when strong stimuli potentially damaging processes to tissues 
occur. A fourth category of “silent” nociceptive fibres are also involved in transduction but only 
when (and if) inflammatory changes occur. All this process is dependant on triggering the 
opening of depolarization of ionic (mainly calcium inflow) and or closing (of potassium 
outflow) channels [125]. 
The second phenomenon involves transmission of impulse (chemical through substance P, 
glutamate and Calcitonin Gene Related Peptide or CGRP, but also electrical through membrane 
depolarization) by the axons from neurons located at the dorsal root ganglia of the posterior 
horn of the spinal cord. They are the primary afferent nerve fibres [124]. Here axons connect to 
numerous “second-order” spinal neurons which cross over to the contralateral side and direct 
the signal upward to the brain via ascending sensory pathways. However, at this spinal level, 
noxious stimulus automatically activate motor neurons from the corresponding ventral horn and 
results in reflex withdraw from insulting agent. The raw neuronal impulses are so modulated in 
the posterior horn where neurons rich in opioid receptors (mu or μ, kappa or κ and delta or δ) 
react to endorphins, substance P and glutamate and either enhanced or dampened the initial 
signal. Second-order neurons may change their response, lowering excitation thresholds and 
expanding receptive fields. This process called central sensitization may exaggerate pain and be 
responsible for allodynia and hyperalgesia both phenomena being harmful to the pain 
perception process. Ascending axons reach the thalamus and a “third-order” neuron is activated, 
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taking the message to the somatosensory cortex [124]. Finally this modulation is probably also 
controlled by descending pathways from higher central nervous system (neurons from the 
frontal cortex, hypothalamus and other areas) to the mid brain and spine via rostral medial 
medulla (RVM), contributing to pain exaggeration or inhibition. 
The final result is conscious awareness or perception of pain which includes all four phases 
together with psychological characteristics of the individual. This is called the Gate Control 
Theory and according to this concept, the fast transmitting Aβ fibres allows the cortex to 
process information and forms a connection with the inhibitory interneuron activity, decreasing 
the neuron's chance of firing, while C fiber's synapse indirectly increase neuron's chance of 
firing and enhance pain [125].  
2.2 Types of Pain [125] 
There are in general four types of pain: 
1. Nociceptive pain 
This sensation is well localized, acute and finite. It results from direct stimulation of nociceptors 
2. Inflammatory pain 
Normally consequence of inflammatory phenomena secondary to primary injury, it is largely 
mediated by nonmyelinated C fibres.   
3. Neuropathic pain  
Caused by injury to peripheral nerves or central nervous system, it typically presents as burning 
or prickling, sensations accompanied by paraesthesia or dysesthesia. It is common in diabetes, 
tumour infiltration, and post-infection such as herpes zoster or chemotherapy. 
4. Functional pain 
Derived from central nervous system abnormal processing of incoming pain stimuli, is very 
common in chronic pain syndromes which are the result of all four types of pain. This 
chronicity of pain arises partially from structural neural plasticity leading to increased 
number of synapses [125]. 
2.3 Visceral Pain versus Somatic pain [126-128] 
Somatic pain in generally sharp, well defined, usually consequence of cutting, perforating, blunt 
trauma, chemical or thermal injury. On contrast, visceral pain is ill defined, aching, dull and 
accompanied by noticeable autonomic symptoms (pallor, hypotension, sweating, nausea or 
vomiting and changes in body temperature) [126, 127]. Visceral pain perception is produced by 
traction on mesentery, distention of hollow organs, strong contraction of smooth muscle layers 
surrounding viscera, ischemia and chemical injury,  but is not originated by cutting or burning 
insults [128]. 
The vagina, cervix and uterus have both somatic and autonomic innervation via sacral plexus, 
pelvic ganglia parasympathetic root (pelvic splanchnic nerves), inferior hypogastric plexus, 
uterovaginal plexus and vaginal nerves. The hypogastric nerve communicates through the 
sympathetic trunk ganglia with the superior hypogastric plexus and via interganglionic branches 
and “rami communicantes” up to segments L2 (lumbar) to T10 (thoracic) level of the spinal 
cord (figure 3).  
So innervation of female genitalia is both somatic and visceral, which poses additional difficulty 
in controlling pain perception. 
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From Sobotta 2006 in http://clinicalgate.com/female-reproductive-system/ 
Figure 3 - Innervation of Female Genital tract 
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2.4 Treatment of Pain [62] [124, 125, 129-133] 
Acetominofen or paracetamol (main sever side effect being hepatotoxicity) and Nonsteroidal 
anti-inflammatory drugs, (NSAIDs) are the first step drugs of choice for pain management and 
are believed to be analgesic by inhibiting prostaglandin formation (not demonstrated for 
paracetamol). NSAIDs inhibit Cyclooxygenase (COX) 1 or COX2 isoform enzyme activity and 
side effects include gastrointestinal ulceration (COX1), inhibition of platelet activity (hence 
anti-aggregating for COX1) or increase action (for COX2) with added risk of thrombosis in the 
latter.   
Opioids have a weak µ or full µ (MOR) opioid agonist receptor activity and block presynaptic 
reuptake of serotonin and norepinephrine or both. Except for meperidine and codeine they do 
not exhibit dose related ceiling. Side effects include addiction, respiratory depression, 
constipation, nausea and vomiting, pruritus, delirium, sedation, allergy, myoclonus and 
tolerance (necessity of increasing dose for the same effect in long term usage).  
Adjuvant agents for pain control may be used and include:  
 Alpha (α) -2 adrenergic agonists (clonidine, tizanidine) have anti- nociceptive spinal 
activity. Administration can be oral, transdermal or epidural. 
 Anticonvulsants (gabapentinoids). They suppress action potential generation in hyper-
excitable neurons and are used normally in neuropathic pain. 
 Antidepressants: Serotonin-norepinephrine reuptake inhibitors (SNRI) and tricyclic 
antidepressants (TAD). These drugs have multiple actions including previously 
mentioned reuptake, but also antihistaminic effect, antagonism of adrenergic α1 
receptors, antagonism at muscarinic receptors and voltage-gated sodium channels. Also 
used normally in neuropathic and chronic pain syndromes, helping in management with 
lower doses of opioids. 
 Bisphosphonates are used in metastatic bone pain unresponsive to analgesia alone. 
 Calcitonin may be used in osteoporosis related pain 
 Corticosteroids may be useful when inflammatory pain is present 
 Topical analgesics (patch) are frequently used for chronic pain [124, 125, 129] .  
 Local anesthetics (lidocaine, ropivacaine, mepivacaine, bupivacaine) are frequently used 
for acute pain to perform nerve blocking [130, 131] and may be suitable for minor 
surgery, local excisions and biopsies and are useful in office procedures. Associated side 
effects include allergic reaction, irritation at the site of injection and local anesthetic 
systemic toxicity (LAST) with cardiomyopathy [132]. 
 Metoclopramide, a dopamine agonist, can be used intravenously in acute migraine as 
adjuvant; it may not relieve pain by itself but it significantly reduces the need for rescue 
drugs [133]. 
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 Treatment of Pain (stepwise) 
Table III 
World Health Organization (WHO) stepwise treatment of pain 
Drugs Mild Pain Moderate Pain Severe Pain 
Non opioids Acetominofen 
NSAIDs 
May associate with 
 
 
May associate with 
Weak opioids  Codeine or 
Tramadol (also has 
weak µ agonist 
activity) 
 
Strong opioid 
(full µ agonist activity) 
  Morphine 
Other opioids 
(meperidine, 
methadone, 
buprenorphine, 
etc.) 
 
 Step 1 Step 2 Step 3 
  
2.5 Pain in Office Hysteroscopy [62, 67-72, 96] 
Pain in office hysteroscopy still poses a problem [62, 67-73, 96] as seen in Table IV. Even the 
most optimistic authors who advocate office hysteroscopy and surgery without analgesia or 
anaesthesia have yet to establish an adequate strategy for painless procedures and we think there 
is room for investigating new approaches which might influence patient’s acceptance of office 
hysteroscopy. 
The original technique of hysteroscopy (and still is performed by many practitioners) involves 
the use of a vaginal speculum, traction upon the cervix with a tenaculum and, if needed, 
dilatation of cervical canal with Hegar dilators and finally the introduction of the hysteroscope. 
It has been established by several authors that a “no touch vaginoscopic approach” is less 
painful than traditional speculum introduction and tenaculum traction [61, 63, 64, 66, 90, 134]. 
Guida in 2006 also established, using pain score evaluation at each phase of the procedure, that 
the most painful step of hysteroscopy was the progression through the cervical canal up and 
through  the internal orifice (phase II of his randomized controlled trial) [63]. So, even if we 
eliminate speculum insertion and vulsellum grip, progression of the hysteroscope through the 
cervical canal will still cause discomfort by stretching of its smooth muscular layer walls, 
especially when traversing the upper (inner) sphincter.  
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2.6 Frequency of pain in Hysteroscopy 
Evaluation of frequency varies with population, methodology of pain assessment and author. As 
shown in table IV, there seems to be a non-negligible percentage of patients for whom the 
procedure is quite uncomfortable.  
 Table IV 
 
Pain evaluation during hysteroscopy 
 
 
 
  
 
  
 Scope size Moderate Severe 
De Angelis Traditional Hysteroscopy 
Mini Hysteroscopy 
57% 
21% 
14% 
2% 
 
Bettocchi (Surgery) 
 
 
Mini Hysteroscopy 
 
5% to 26% 
 
No record 
 
Campo 
 
Traditional Hysteroscopy 
Mini Hysteroscopy 
 
Mean VAS 2.8 
Mean VAS 1.8 
 
No record 
 
Van den Bosch 
 
Endometrial biopsy 
Mini Hysteroscopy 
 
Median 5.1  
Median 2.7 
 
No record 
 
Diniz 
 
Traditional Hysteroscopy 
Mini Hysteroscopy 
 
 
32% 
32% 
 
41.4% 
20.3% 
Paulo 2015 
Systematic Review  
 
Mini Hysteroscopy 
Mini hysteroscopy 
30% (VAS ≥ 4) 
13% (VAS ≥ 5) 
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PART II – RESEARCH  
1. Goals of Research 
 
1)  To evaluate if pain perception can be reduced by decreasing the hysterocope diameter  
 
2) To determine the proportion of women who will still complain of discomfort with 
smaller endoscopes  
 
3) To assess whether other clinical factors may influence pain perception in office 
hysteroscopy  
 
4) To determine if psychological profile of women can influence pain and if satisfaction 
questionnaires correlate well with pain  
 
 
5) To evaluate if the new anaesthetic approach can effectively reduce discomfort in Office 
Hysteroscopy 
     
6) To suggest future work in order to elaborate guidelines and strategies for pain 
evaluation in real time and reduce the distress associated with hysteroscopy  
 
 
For each of these objectives an investigation was conducted. Five papers were published with 
interesting conclusions. Results will be discussed and future perspectives set forth and 
suggested.   
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2. Materials and methods 
 
1) Our first paper “Is pain better tolerated with mini-hysteroscopy than with conventional 
device? A systematic review and meta-analysis”, was processed according to the 
protocol registration http://www.crd.york.ac.uk/PROSPERO/ CRD42014010672. 
Studies were sought with key words “hysteroscopy” and “pain” from the following 
sources: Pubmed/ Medline (465), Portal de Pesquisa da BVS (214), LILACS (13) 
CINHAL, Embase and Cochrane database (82) Cochrane systematic reviews (3) DARE 
systematic reviews (4) IBECS (3)  Scielo (8) Global Health Library (GHL), (20) 
Western Pacific region Health Index  ( WPRIM ) (12) Index Medicus for the Eastern 
Mediterranean Region (IMEMR) (8) and Index Medicus for South-East Asia 
Region (IMSEAR) (1)  giving a total 834 hits. Time frame was from 2000 onward. 
After reading titles and eliminating duplicates, 94 abstracts were independently assessed 
by three authors (A.P., M. S. and C.P.) and of theses, 33 articles retrieved for detailed 
analysis. Seven high quality papers from Randomized Controlled Trials (RCT) which 
included eight studies involving a total of twenty three hundred and twenty two women 
were selected from literature sources.  RevMan 5.0  (a standard meta-analysis software) 
was used and we computed standardized mean differences also known as Cohen’ d and 
95% confidence intervals (CI) for all studies. Heterogeneity was tested using the Q 
statistic and the I^2 statistic and we assessed for bias using the Cochrane tool for bias 
assessment. 
2) Our second paper “What proportion of women refer moderate to severe pain during 
Office Hysteroscopy with a mini-hysteroscope? A systematic review and meta-analysis” 
was also processed in accordance to the protocol registration 
http://www.crd.york.ac.uk/PROSPERO/CRD42014010557. 
Studies were sought with key words “hysteroscopy” and “pain” from 2000 to December 
2014 from the following sources: Pubmed/ Medline, CINHAL, Embase and Cochrane 
database, Cochrane systematic reviews, Portal de Pesquisa da BVS, LILACS, DARE 
systematic reviews, IBECS, Scielo, Global Health Library (GHL), Western Pacific 
region Health Index (WPRIM ) Index Medicus for the Eastern Mediterranean Region 
(IMEMR) and Index Medicus for South-East Asia Region (IMSEAR), giving a total 
863 hits. After reading titles and eliminating duplicates, 94 abstracts were 
independently assessed by four authors (A.P., M. S., C.P. and V.A.) and of these, 35 
articles retrieved for detailed analysis involving a total of seventeen hundred and sixty 
one women were included and analyzed. Letters requesting data lacking were sent to 
authors in an attempt to complete the study with as much data as possible. It was 
impossible to retrieve original data in ten, four were reviews and in the remainder, 
various medications or other interventions were associated with hysteroscopy and so 
were considered by revision authors to potentially alter results. MetaXL 1.0. (EpiGear 
International Pty Ltd, Wilston, Queensland, Australia) was used to pool individual 
prevalence from each study. We reported the estimated prevalence for all studies and by 
two subgroups: (i) RCT and (ii) Prospective Trials (PT) reporting prevalence with 95% 
confidence intervals. Due to significant heterogeneity between studies, we estimated the 
pooled prevalence for each group using the random-effects model. 
3) Our third paper was based on a Prospective Cohort Observational Trial (PT) registered 
at ClinicalTrials.gov Protocol and Results Registration System NCT02543515 under the 
general name “Psychosocial and Clinical Characteristics Predicting Women's 
Acceptance of Office Hysteroscopy. This trial was the basis for three papers following 
analyzes of data extracted from our database enrolling one hundred and eighteen 
patients scheduled for Office Hysteroscopy (OH) at Centro Hospitalar Tondela-Viseu, 
Portugal. One hundred cases were included and statistical analysis for “Hysteroscopy 
and pain: what risk factors should we consider in office hysteroscopy? are there really 
any?” was performed with SPSS 22.0 IBM for windows and in a statistical hypothesis 
PSYCHOSOCIAL AND CLINICAL CHARACTERISTICS PREDICTING WOMEN’S ACCEPTANCE OF OFFICE 
HYSTEROSCOPY 
17 
 
test with a p value < 0.05 the effect was considered significant so confidence intervals 
are reported with 95% assurance level. We conducted multivariate ordered logistic 
regression analysis exploring the effect of menopause, dysmenorrhea and history of 
menorrhagia, parity of women, previous cervical surgery and age in pain score. 
4) Our fourth article “Pain, anxiety and patient satisfaction in office hysteroscopy, is there 
a link? Are patient satisfaction questionnaires reliable?” was written on results from 
the same Trial nº NCT02543515 registered at ClinicalTrials.gov Protocol and Results 
Registration System.  One hundred women scheduled for Office Hysteroscopy were 
included and analyzed. Analysis was performed with SPSS 22.0 IBM for windows and 
in a statistical hypothesis test with a p value < 0.05 the effect was considered 
significant. The confidence intervals are consequently reported with a 95% assurance 
level. The normal goodness of fit testing was applied for all quantitative variables. 
Kolmogorov-Smirnov test revealed that for almost all quantitative variables the normal 
distribution fit is rejected. In accordance we performed non parametric statistical tests. 
Kruskal Wallis test was used to evaluate the association between the pain score and the 
satisfaction variables, Spearman’s correlation was used to correlate anxiety and pain, 
and finally Receiver Operating Characteristic (ROC) were constructed with answers 
from satisfaction questionnaires  in order to establish cutoff points. 
5) For our fifth article “Office Hysteroscopy and pain control, a multicenter study 
comparing pain by scope size. Introducing the novel “hysteroscopic anaesthesia” 
technique” we invited the Department of Gynaecology of Hospital das Forças Armadas 
Lisboa, Portugal who contributed with eighty one women scheduled for OH for a 
multicenter prospective observational study. The Department of Obstetrics and 
Gynecology of Centro Hospitalar Tondela-Viseu, Portugal enrolled one hundred 
women. Protocols’ had slight differences in scope size (3.5mm at Viseu versus 5mm at 
Lisboa), use of an innovating local anaesthesia in Lisboa and pain score evaluation 
which was Visual Analogue Scale (VAS) scoring in Viseu and a Numeric Rating Scale 
(NRC) in Lisboa. Statistical analysis was performed with SPSS 22.0 IBM for windows 
and in a statistical hypothesis test with a p value < 0.05 the effect was considered 
significant.  
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3. Results and findings 
 
  
PSYCHOSOCIAL AND CLINICAL CHARACTERISTICS PREDICTING WOMEN’S ACCEPTANCE OF OFFICE 
HYSTEROSCOPY 
19 
 
Paper number one: “Is pain better tolerated with mini-hysteroscopy than with conventional 
device? A systematic review and meta-analysis”, was processed according to the protocol 
registration http://www.crd.york.ac.uk/PROSPERO/ CRD42014010672. 
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Paper number two:  “What proportion of women refer moderate to severe pain during Office 
Hysteroscopy with a mini-hysteroscope? A systematic review and meta-analysis” was also 
processed in accordance to the protocol registration 
http://www.crd.york.ac.uk/PROSPERO/CRD42014010557
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Paper number three: “Hysteroscopy and pain: what risk factors should we consider in office 
hysteroscopy? Are there really any?”  
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Paper number four: “Pain, anxiety and patient satisfaction in office hysteroscopy, is there a 
link? Are patient satisfaction questionnaires reliable?”  
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Paper number five: “Office Hysteroscopy and pain control, a multicenter study comparing 
pain by scope size. Introducing the novel “hysteroscopic anaesthesia” technique”  
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PART III – DISCUSSION AND CONCLUSIONS 
1. Discussion 
Hysteroscopy as a tool can be used both with a diagnostic and a therapeutic approach. As 
Mairos et al point out [83], hospitalization exposes patients to adverse event or injury related to 
medical management and 1 of 10 will suffer damage in contrast to complications of the disease 
itself [135, 136]. This makes office procedures not only cost effective, but in fact safer for 
patients and goes in line with WHO Alliance for Patient Safety policy.  
Hysteroscopy remains a gold standard technique [137] for diagnostics [137] and surgical 
treatment of intracavitary lesions [68] [83]. In office setting hysterocopy’s main drawback is 
pain [62, 68, 137] as Favilli et al observe in a comment on our article “Is pain better tolerated 
with mini-hysteroscopy than with conventional device?” [138]. He does stress out and we 
concur, that the issue of pain will not be solved exclusively reducing scope size.  
Several authors have written on pain reducing techniques [62, 68], with a special focus on using 
a vaginoscopic “no touch” approach [63, 64, 84, 90, 134, 139, 140] and this points seems settled 
by Cooper et al in her systematic review as a statistical significance was found between lower 
pain perception and the vaginoscopic approach [66].  
As for analgesia and local anaesthetics, Ahmad’s et al Cochrane review of 2010 addresses local 
anaesthetics (various routes of administration) with conflicting results, NSAID (used in the 
hypothesis that prostaglandin release may cause pain), buprenorphine, the anti-spasmodic 
drotaverine hydrochloride combined with mefenamic acid and intravenous sedation in various 
settings[141]. He concludes there is a statistically significant decrease in pain reporting with 
local anesthetics, but mean pain reduction is small. Likewise Cooper addresses the issues of 
topical anaesthetic agents applied locally, or intracervical, paracervical and intrauterine 
(transcervical local) administration, intramuscular (IM) use of tramadol and use of conscious 
sedation. Her results show local anesthetic reduce pain experienced during outpatient 
hysteroscopy when used in paracervical and intracervical injections, but not with transcervical 
and topical application [72]. She concludes injectable, preferably paracervical, administration of 
local anesthetic should be used for women undergoing hysteroscopy as outpatients to reduce the 
amount of pain experienced.  Although her conclusions point to usage of these drugs, the 
strength of her results is small and she does mention the need for large trials to confirm her 
findings. She also cautions that administration of such drugs may have side effects and results 
do not include pain relieve in hysteroscopy surgery.  
In 2003 De Angelis et al published a paper reporting the use of transcutaneous electrical nerve 
stimulation (TENS) for pain relieve in hysteroscopy [142]. The rational for this study was that 
the stimuli would act on large-diameter “A” fibers (according to the “gate control” theory) 
establishing a blockade or “gating effect” at the dorsal horn of the spinal cord, thus preventing 
pain from being transmitted to the upper nervous system. They compared seventy one patients 
in each or the two arms and found a statistical significant difference between groups of users 
and controls. No other study has confirmed this result in hysteroscopy. 
Finally, as to distension media and pain, Pluchino et al [143] and Cicinelli et al [140, 144] found 
normal saline to be less painful than CO2, but Cooper et al in 2010 published a systematic 
review where she discussed utility, quality of vision and pain [145]; this study did not support 
this point of view. It concluded both CO2 and normal saline are adequate for office 
hysteroscopy and pain did not show statistical difference between either, but as normal saline 
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allows surgery with bipolar electrodes, it would probably by more convenient if surgery in 
foreseen. 
Lowering pain perception can be done with reduction in the calibre of instruments as several 
RCT have shown [62, 68, 90, 140, 146, 147], while others [137, 148] could not sanction this 
effect;  there was no systematic review confirming these data. To tackle this question in 2015 
we published a paper entitled “Is pain better tolerated with mini-hysteroscopy than with 
conventional device? A systematic review and meta-analysis.” Our results showed a statistically 
significant lowering of pain scores with slenderer scopes (3 to 3.6mm outer sheet diameter) but 
also suggested there may be a cutoff around 3.5mm below which further reduction in caliber 
may not result in better tolerance.  
Another query which we undertook was to estimate how many women still complained of pain 
with smaller scopes. We published in 2015 this paper “What proportion of women refers 
moderate to severe pain during office hysteroscopy with a mini-hysteroscope? A systematic 
review and meta-analysis”. To the best of our knowledge this was this first ever study seeking 
trials or arms within a trial where only the better tolerated “mini-hysteroscope” was used. We 
reached the conclusion that mini-hysteroscopy remains painful for at least 13 % of women if 
cut-off for moderate pain is set at VAS ≥ 5 but it reaches over thirty percent if cut-off switches 
to a more acceptable and consensual value of VAS ≥ 4.  
Several clinical and psychological factors have been suggested to influence pain reporting. 
Menopause is one such factor found associated to higher pain scores [137, 144] while other 
authors did not find such difference [148].  Previous cesarean section [144] and chronic pelvic 
pain [144, 149] were found by logistic regression to significantly correlate with higher pain at 
hysteroscopy, while anxiety  showed a mildly significant correlation with pain [144]. But on the 
other hand Sessa could not find significance in pain in women with history of cesarean section 
[150]. Operator experience [143, 149] and shorter duration of procure seem to have a protective 
roll [149]. Body mass index (BMI) may associate with less pain reporting [151]. Vaginal or 
cervical stenosis can be reason for pain and preclude the completion of hysteroscopy [146, 152]. 
With our prospective study “Hysteroscopy and pain: what risk factors should we consider in 
office hysteroscopy? Are there really any?” we tried to answer these questions. We did not find 
significance in pain reporting through ordered logistic regression with menopause, 
dysmenorrhea, and history of menorrhagia or parity of women. The only variable we found to 
have significance was BMI and our conclusion was obesity may have impact on pain, reducing 
its perception, probably related to higher estrogen levels in overweight women. 
Anxiety and its effect on pain at hysteroscopy was studied by Kokanali et al [153] and they 
found a positive correlation with both STAI-Y1 and STAI-Y2 scores and pain. Additionally 
they also found significance with in-hospital waiting time for both anxiety and pain scores. One 
the other hand Carta et al found no significant correlation between anxiety scores and pain 
reporting [154]; he did find significance, although with a weak correlation, to waiting time 
greater than sixty minutes and in women who are in menopause. Our results in “Pain, anxiety 
and patient satisfaction in office hysteroscopy, is there a link? Are patient satisfaction 
questionnaires reliable?” showed no correlation between STAI-Y1 and severity of pain, with a 
meek influence of STAI-Y2 scores on pain. As to satisfaction questionnaires, they proved to be 
reliable, with both excellent specificity (72%) and sensitivity (94%). Three answer 
questionnaires are simple to administer, easy to interpret and may prove be very helpful in 
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clinical practice (especially in departments where local anaesthesia is administered “if 
necessary”). 
Much has been written on local anaesthetics and hysteroscopy, with both systematic reviews 
from Cooper et al [72] and Ahmad et al [141] finding significance, if small, for pain control in 
office hysteroscopy and perhaps this is the reason why the Royal College of Obstetricians and 
Gynaecologists, despite recommending topical, local and transcervical anaesthetics, emphasises 
that no significant reduction in pain was demonstrated (transcervical application). [155]  
In our article “Office hysteroscopy and pain control, a multicenter comparison by scope size 
and introducing a novel “hysteroscopic anesthesia” technique” we emphasize the original 
mode of administration of the local anaesthetic (which is injected under direct and live view) 
through the hysteroscope to the exact location where pain is felt during the procedure. This may 
account for the dramatic change of pain scores before and after injection (via a 35 cm long 
Cystoscopy Injection Needle).   
As to the other conclusions of this trial, we did not find significance between pain felt with 
mini-hysteroscopy and conventional (5mm) hysteroscopy; however, one should take into 
account two circumstances: first each Centre only used either 3.5mm or 5mm scopes, and 
second pain evaluation was done with two different tools (VAS in Viseu and NRS in Lisboa). 
Finally there is a variation in population: Viseu is mainly a medium sized city with the majority 
of women being of civilian and rural extraction, while in Lisboa patients are mostly urban, 
military personnel or their relatives. These biases might influence pain reporting and preclude 
our expected differences in pain by scope size to show statistical significance. 
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2. Conclusions: 
 
1) Mini-hysteroscopy is less painful than conventional 5mm hysteroscopy and, in line with 
RCOG/BSGE recommendations, should be preferred in outpatient diagnostic 
hysteroscopy [155]. 
 
2) Even when mini-hysteroscopy is used, pain may be present in 13% to 30% of women 
depending on what cutoff we use for mild pain (VAS≥5 or VAS≥4 respectivly). 
 
3) The only predictive factor that showed significance (protecting from pain at 
hystersocopy) was elevated BMI. Previous cesarean section, menopausal state, history 
of pelvic pain and dysmenorrhea do not seem to influence discomfort. As for cervical 
surgery and/or stenosis, there were not enough cases represented to support any kind of 
opinion. 
 
4) Anxiety may not be an important factor in pain, even if anxiety trait might have a very 
slight influence. This could sugest anxious women can benefit from a short-acting 
anxiolytic such as midazolam.  
 
5) Satisfaction questionnaires seem promissing and reliable for use instead of 10cm VAS 
or NRS, more complicated to understand by patient. A three question anwer could 
probably be used in the office and help decide which woman should have local 
anaesthetic to ease pain. 
 
6) Although further studies are warrented to acertain its utility, hysteroscopic anaesthesia 
seems promising in making the procedure tolerable for most women. 
 
3. Future perspectives: 
We recognize changing attitudes is a slow process and physicians always seek hard facts to 
adjust their protocols. Therefore it is highly desirable that well designed RCT’s comparing 
pain at hysteroscopy with and without hysteroscopic anaesthesia be undertaken to evaluate 
and either attest or refute the benefits of this promising intervention, which we think, may 
prove very useful.  
Assessment of utility of three answer questionnaires and validation of these as a scoring tool 
in the same RCTs would help corroborate our other findings and bring this simple tool into 
daily practice.  
Finally, risk factors predicting pain at hysteroscopy will probably remain under debate for 
some time. We do however think, that as soon as a suitable analgesia (or local anaesthesia 
technique) is in place, the question of risk factors for pain will most likely become obsolete.  
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